ユタにおける間質性肺疾患の臨床試験
ユタ内の拠点で、間質性肺疾患に関する9件の研究が参加者を募集しています。
ユタ内の都市
公式研究テキスト（英語）
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University of Utah Health Sciences Center, Salt Lake City
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07540988Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA025, Salt Lake City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07179380A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Salt Lake City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06572384A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Utah, Salt Lake City
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/04更新 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Utah, Salt Lake City
被験者募集中
18歳以上 · 全性別 · 2026/09/02更新 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Intermountain Medical Center, Murray
- University of Utah Health, Salt Lake City
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/26更新 · NCT06388421Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Utah, Salt Lake City
被験者募集中観察研究
21歳以上 · 全性別 · 2026/08/12更新 · NCT01915511Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Intermountain Medical Center, Murray
- University of Utah Health, Salt Lake City
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/13更新 · NCT05943535Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Salt Lake City
被験者募集中第2相
18歳以上 · 全性別 · 2025/05/07更新 · NCT05892614ClinicalTrials.govより、2026/10/03時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。